LAMISIL 250 (Lamisil 250 mg)
Generic Name: terbinafine
Pill imprint LAMISIL 250 has been identified as Lamisil 250 mg.
Lamisil is used in the treatment of cutaneous candidiasis; onychomycosis, toenail; tinea corporis; tinea pedis; tinea cruris (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy. Lamisil 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for LAMISIL 250 (Lamisil 250 mg)
- Generic Name:
- terbinafine
- Imprint:
-
LAMISIL
250 - Strength:
- 250 mg
- Color:
- White
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0179
- Inactive Ingredients:
- silicon dioxide
hypromelloses
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
| NDC Code | Manufacturer / Repackager |
|---|---|
| 55289-0513 | PDRX Pharmaceuticals Inc (repackager) |
| 54868-4008 | Physicians Total Care Inc (repackager) |
| 49999-0466 | Lake Erie Medical and Surgical Supply (repackager) |
| 23490-6961 | Palmetto State Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More resources
Lamisil is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
